臍帯血バンクの世界市場規模：バンクタイプ別、用途別、エンドユーザー別、地域別、範囲および予測

臍帯血バンク市場の規模と予測

臍帯血バンク市場規模は、2023年に20億5,000万米ドルと評価され、2024年から2031年にかけてCAGR 14%で成長し、2031年には66億7,000万米ドルに達すると予測されます。臍帯血バンクとは、臍帯血を採取し、幹細胞やその他の免疫系細胞を抽出し、将来の医療利用のために低温保存するプロセスです。出生後、へその緒と胎盤に留まる血液は臍帯血（umbilical cord bloodの略）として知られています。母体と胎児の細胞移植は、出産に備えて母親と赤ちゃんの免疫系を強化するために、臨月またはその近くに行われます。

臍帯血には多数の幹細胞が含まれており、80以上の遺伝性疾患を治療することができます。これらの病気には、がん、血液疾患、糖尿病、免疫疾患などが含まれ、すべて臍帯血幹細胞で治療することができます。

臍帯血バンクの世界市場は、治療応用の進歩、新興国市場における未開拓の機会、認知度を広めるための取り組みなどにより、拡大が見込まれています。

世界の臍帯血バンク市場力学

世界の臍帯血バンク市場を形成している主な市場力学

主な市場促進要因

マインドフルネスの高まり：

臍帯血バンクの利点、例えばさまざまな病気や問題を治療する能力について、熱心な保護者の間で意識が開発され、臍帯血バンク業務への関心が高まっています。

臨床検査の進歩：

臨床研究、特に再生医療と基礎微生物治療における絶え間ない進歩は、臍帯血未分化生物の期待される用途を拡大し、その結果、臍帯血バンクへの関心を高めています。

進行性疾患の増加：

白血病、リンパ腫、遺伝性疾患のような永続的な病気の増加傾向は、臍帯血の有効性の分野で進行中の研究開発を支援するために、先進治療、特に遺伝子ベースの治療の適用を急増させています。このように、臍帯血の利点に関する意識の高まりと調査支援が、さまざまな地域で臍帯血バンクの採用を促進しています。

政府の推進と支援：

公的臍帯血提供センターの設立と並んで、未分化細胞の検査と移植を支援する政府の推進策とガイドラインは、臍帯血バンク市場への配慮と利用可能性を促進することにより、臍帯血バンク市場の開拓を支援しています。

機械的進歩：

臍帯血の取り扱い、備蓄、移植手順における革新的な進歩は、臍帯血未分化生物の合理性と生存性に働きかけ、臍帯血バンクを保護者や医療サービス業者にとってより魅力的な選択肢にしています。

医療消費の拡大：

特に新興経済圏における医療利用の増加と医療基盤への関心の高まりが、臍帯血バンク事業の受容を促進し、この事業の発展を支えています。

主な課題：

制限されたマインドフルネス：

臍帯血バンクの利点があるにもかかわらず、希望に満ちた保護者の間では、臍帯血と組織保護の重要性についての認識がまだ限定的です。臍帯血の潜在的な回復用途に関する認知度の向上が試されています。

多額の費用：

臍帯血バンクの管理には、導入的な取り扱いや保管料、進行中の維持費など、法外な費用がかかることがあります。臍帯血バンクに多額の費用がかかるため、特に医療費が保護の対象外であったり、一部の人々にとって制限の多い地域では、臍帯血バンクを選択肢として考えることを思いとどまる家族もいるかもしれないです。

道徳的な懸念

臍帯血バンクの商業化をめぐっては、特に臍帯血の使用に関する倫理的な問題があります。文化的な制約があるため、今後数年間は臍帯血バンクの導入が減少する可能性が高いです。

管理上の困難：

臍帯血バンクは、多くの国の行政監督に依存しており、行政上の必要事項への適合は、気の遠くなるような面倒な作業です。臍帯血ユニットの選別、取り扱い、備蓄、普及に関するガイドラインとの整合性を保証することは、市場に計算された権威ある困難をもたらします。

容量の限界：

臍帯血バンクユニットの生産能力の限界は、年々増加する臍帯血の収集数を満たすことができないです。容量の制約が現れると、廃棄される臍帯血ユニットの量が増加し、そのためフレームワークの開発と技術革新に関心が必要となります。

主要動向：

認識と受容の高まり：

臍帯血由来の幹細胞を用いて様々な疾患や病態を治療できる可能性など、臍帯血バンクの利点に対する妊産婦の意識が高まっています。こうした認識と受容の高まりが、臍帯血バンク・サービスの需要を世界的に牽引しています。

技術の進歩：

幹細胞の分離、処理、凍結保存技術の向上を含む技術の進歩は、保存される臍帯血の品質と生存可能性を高めています。このような技術の進歩により、臍帯血バンクはより効果的で信頼性の高いものとなり、より多くの顧客を惹きつけています。

公的臍帯血バンクの拡大：

公的臍帯血バンクは、移植や研究目的のために臍帯血幹細胞へのアクセスを提供する上で、ますます重要な役割を果たしています。政府やヘルスケア機関は、必要とする患者のために多様で高品質な臍帯血ユニットの利用可能性を高めるため、公的臍帯血バンクのインフラ拡大に投資しています。

目次

第1章 世界の臍帯血バンク市場のイントロダクション

• 市場のイントロダクション
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界の臍帯血バンク市場の展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 世界の臍帯血バンク市場、バンクタイプ別

• 概要
• 民間
• 公的
• ハイブリッド

第6章 臍帯血バンクの世界市場：用途別

• 概要
• 血液悪性腫瘍
• 非悪性疾患
• 再生医療

第7章 臍帯血バンクの世界市場：エンドユーザー別

• 概要
• 病院
• 研究機関
• その他

第8章 臍帯血バンクの世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界の臍帯血バンク市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Lifeforce Cryobanks
• China Cord Blood Corporation
• Cordlife Group
• Virgin Health Bank
• Cord Blood America
• CBR Systems
• Cryo-Cell International
• ViaCord
• National Cord Blood Program
• Americord

第11章 主な発展

• 製品上市／開発
• 合併と買収
• 事業拡大
• パートナーシップと提携

第12章 付録

• 関連調査

Cord Blood Banking Market Size And Forecast

Cord Blood Banking Market size is valued at USD 2.05 Billion in 2023 and is projected to reach USD 6.67 Billion by 2031, growing at a CAGR of 14% from 2024 to 2031. Cord blood banking is the process of taking cord blood, extracting its stem cells and other immune system cells, and cryogenically storing them for future medical use. The blood that stays in the umbilical cord and placenta after birth is known as cord blood (short for umbilical cord blood). A maternal-fetal cell transfer occurs at or near term to enhance the immune systems of both the mother and the baby in preparation for childbirth.

Cord blood includes a large number of stem cells that can be used to cure over 80 hereditary illnesses. These illnesses include cancer, blood illnesses, diabetes, and immunological diseases, all of which can be treated with cord blood stem cells.

The Global Cord Blood Banking Market is expected to rise due to advancements in therapeutic application, untapped opportunities in developing regions, and initiatives to spread awareness.

Global Cord Blood Banking Market Dynamics

The key market dynamics that are shaping the global Cord Blood Banking Market include:

Key Market Drivers:

Increasing Mindfulness:

Developing mindfulness among eager guardians about the advantages of cord blood banking, for example, its capability to treat different sicknesses and problems, is driving interest for cord blood banking administrations.

Progressions in Clinical Exploration:

Continuous headways in clinical examination, especially in regenerative medication and foundational microorganism treatment, are extending the expected uses of line blood undifferentiated organisms, consequently driving the interest for cord blood banking.

Rising Commonness of Ongoing Diseases:

The rising predominance of persistent sicknesses like leukemia, lymphoma, and hereditary issues is surging the application of advanced treatments, especially genetic-based therapies, to support the ongoing research and development in the field of effectiveness of cord bloods. Thus, the growing awareness regarding the benefits of cord blood and supporting research are driving the adoption of cord blood banking across diverse regions.

Government Drives and Backing:

Government drives and guidelines supporting undifferentiated cell examination and transplantation, alongside the foundation of public cord blood donation centers, are helping the development of the Cord Blood Banking Market by advancing mindfulness and availability.

Mechanical Progressions:

Innovative headways in cord blood handling, stockpiling, and transplantation procedures have worked on the reasonability and viability of line blood undifferentiated organisms, making cord blood banking a more alluring choice for guardians and medical services suppliers.

Expanding Medical Care Consumption:

Rising medical care use and interests in medical care foundation, especially in arising economies, are driving the reception of cord blood banking administrations and supporting the progression of this business.

Key Challenges:

Restricted Mindfulness:

Despite the likely advantages of cord blood banking, there is as yet restricted mindfulness among hopeful guardians about the significance of cord blood and tissue protection. Growing awareness about its potential restorative applications stays a test.

Significant Expense:

Cord blood banking administrations can be exorbitant, including introductory handling and stockpiling charges along with progressing upkeep charges. The significant expense of string blood banking might dissuade a few families from considering it as a choice, especially in districts where medical care costs are not covered by protection or are restrictive for some.

Moral Worries:

There are moral contemplations surrounding the commercialization of cord blood banking, especially the ethical issues concerning the use of cord blood. The cultural restrictions are likely to decrease its adoption in the coming years.

Administrative Difficulties:

Cord blood banking is dependent upon administrative oversight in numerous nations, and consistence with administrative necessities can be mind boggling and tedious. Guaranteeing consistence with guidelines for assortment, handling, stockpiling, and dissemination of cord blood units presents calculated and authoritative difficulties for the market.

Capacity Limits:

The capacity limitations of cord blood banking units is unable to meet the increasing number of cord blood gathered every year. As the capacity constraints emerge, the volume of discarded cord blood units increments, thereby requiring interests in framework development and innovation.

Key Trends:

Increasing Awareness and Acceptance:

There is growing awareness among expectant parents about the benefits of cord blood banking, such as the potential to treat various diseases and conditions using stem cells derived from cord blood. This increased awareness and acceptance are driving demand for cord blood banking services globally.

Technological Advancements:

Advances in technology, including improvements in stem cell isolation, processing, and cryopreservation techniques, are enhancing the quality and viability of stored cord blood units. These technological advancements are making cord blood banking more effective and reliable, thus attracting more customers.

Expansion of Public Cord Blood Banks:

Public cord blood banks are playing an increasingly important role in providing access to cord blood stem cells for transplantation and research purposes. Governments and healthcare organizations are investing in the expansion of public cord blood banking infrastructure to increase the availability of diverse and high-quality cord blood units for patients in need.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Global Cord Blood Banking Market Regional Analysis

Here is a more detailed regional analysis of the global Cord Blood Banking Market:

North America:

North America has a well-established healthcare system and a high degree of knowledge among pregnant parents about the benefits of cord blood banking. As a result, the region has a higher adoption rate of cord blood banking services than other parts of the world, enabling the region dominate the market.

The regulatory frameworks governing cord blood banking in North America are well-established and supportive public and private banks. Regulatory authorities, such as the FDA (Food and Drug Administration) in the United States, establish standards and oversight to ensure cord blood banking techniques are safe and effective.

The region is at the forefront of scientific developments in healthcare, such as stem cell research and biotechnology. This technological skill allows North American cord blood banks to offer state-of-the-art storage and processing facilities, enhancing the quality and viability of stored cord blood units.

Asia Pacific:

Asia Pacific has a huge and quickly growing population, with countries such as China, India, and Southeast Asian nations seeing rise in birth rates. This demographic trend is generating demand for cord blood banking services as more parents learn about the benefits of keeping cord blood for future medical use.

Rising disposable incomes and growing middle-class populations in Asia Pacific countries are driving up spending on healthcare services, especially prenatal and neonatal care. This rising healthcare spending is fueling demand for innovative medical technologies, such as cord blood banking, to protect the health and well-being of newborns and pregnant women.

Healthcare professionals, patient advocacy groups, and educational institutions throughout Asia Pacific are raising awareness about the medicinal potential of cord blood stem cells.

Global Cord Blood Banking Market: Segmentation Analysis

The Global Cord Blood Banking Market is segmented on the basis of Bank Type, Application, End-User, And Geography.

Cord Blood Banking Market, By Bank Type

• Private
• Public
• Hybrid

Based on Bank Type, The market is segmented into Private, Public, and Hybrid. The private cord blood banking segment holds the largest market share, accounting for approximately 80% of the global market revenue. On the other hand, the public cord blood banking segment is expected to grow at a faster rate in the coming years due to increasing government support for public cord blood banking programs and growing awareness of the ethical implications of private cord blood banking.

Cord Blood Banking Market, By Application

• Hematological Malignancies
• Non-Malignant Diseases
• Regenerative Medicine

Based on Application, The market is segmented into Hematological Malignancies, Non-Malignant Diseases, and Regenerative Medicine. The hematological malignancies is expected to dominate the global Cord Blood Banking Market over the forecast timeframe. Growing presence of cancer is surging the need for cord blood banking for effective treatment, thereby enabling this segment retain its top position. While other applications such as non-malignant diseases and regenerative medicine is anticipated to be promising, their widespread adoption in the clinical sector is still in its early stages.

Cord Blood Banking Market, By End-User

• Hospitals
• Research Institutes
• Others

Based on End-User, The market is segmented into Hospitals, Research Institutes, and Others. As per our analyst, hospitals segment is estimated to hold large share in the market. Increasing child birth in hospitals acts a primary point of contact in facilitating cord blood collection. Also, the availability of well-equipped infrastructure and healthcare professionals to safely collect, process, and store cord blood samples for potential future use will help hospitals keep contact with well-known cord blood banking.

Key Players

• The " Global Cord Blood Banking Market" study report will provide a valuable insight with an emphasis on the global market. The major players in the market are
• Lifeforce Cryobanks, China Cord Blood Corporation, Cordlife Group, Virgin Health Bank, Cord Blood America, CBR Systems, Cryo-Cell International, ViaCord, National Cord Blood Program, Americord, StemCyte, Cryo-Save Group, NeoStem, and Blood Centers of America.

Our market analysis includes a section specifically devoted to such major players, where our analysts give an overview of each player's financial statements, along with product benchmarking and SWOT analysis. Key development strategies, market share analysis, and market positioning analysis of the aforementioned players globally are also included in the competitive landscape section.

• Cord Blood Banking Market Recent Developments
• In May 2021, SingHealth Duke-NUS Academic Medical Centre and Cordlife announced their partnership. This strategy will benefit the company in developing new technologies related to stem cell and blood therapies and increase its share in the industry.
• In August 2019, Cordlife announced its geographical expansion into Bangladesh. This strategy benefited the company to expand its geographical footprint and acquired a larger market share.
• In January 2024, DKMS Chile launched first collection center in Santiago de Chile to enhance stem cell collection as well as transplant capacity in the country and improve access to treatment for patients in need.

TABLE OF CONTENTS

1 INTRODUCTION TO THE GLOBAL CORD BLOOD BANKING MARKET

• 1.1 Introduction of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL CORD BLOOD BANKING MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL CORD BLOOD BANKING MARKET, BY BANK TYPE

• 5.1 Overview
• 5.2 Private
• 5.3 Public
• 5.4 Hybrid

6 GLOBAL CORD BLOOD BANKING MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Hematological Malignancies
• 6.3 Non-Malignant Diseases
• 6.4 Regenerative Medicine

7 GLOBAL CORD BLOOD BANKING MARKET, BY END-USER

• 7.1 Overview
• 7.2 Hospitals
• 7.3 Research Institutes
• 7.4 Others

8 GLOBAL CORD BLOOD BANKING MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 The U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 The U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL CORD BLOOD BANKING MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Lifeforce Cryobanks
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 China Cord Blood Corporation
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Cordlife Group
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Virgin Health Bank
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Cord Blood America
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 CBR Systems
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Cryo-Cell International
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 ViaCord
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 National Cord Blood Program
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Americord
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

• 11.1 Product Launches/Developments
• 11.2 Mergers and Acquisitions
• 11.3 Business Expansions
• 11.4 Partnerships and Collaborations

12 Appendix

• 12.1 Related Research